Press release
04.10.2021 To the attention of interested persons EMA receives application for marketing authorisation for Regkirona (regdanvimab) for treating patients with […]
Press release
01.10.2021 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 September 2021 download […]
Press release
01.10.2021 To the attention of interested persons EMA starts review of meningioma risk with nomegestrol- and chlormadinone-containing medicines download document […]
Important notification
30.09.2021 To the attention of all importers and distributors of medical devices The NAMMDR warns all importers and distributors of […]
Press release
27.09.2021 To the attention of interested persons EMA evaluating data on booster dose of COVID-19 vaccine Spikevax download document …
Important notification
24.09.2021 To the attention of all importers and distributors of medical devices The NAMMDR warns all importers and distributors of […]
Important notification
24.09.2021 To the attention of all importers and distributors of medical devices The NAMMDR warns all importers and distributors of […]
Important notification
21.09.2021 To the attention of all wholesale distributors of medicinal products, authorised in Romania According to Minister of Health no. […]
Important notification
13.09.2021 To the attention of all wholesale distributors of medicinal products for special needs Considering the provisions of Art. 15 […]
Press release
09.09.2021 To the attention of interested persons Increase in manufacturing capacity for COVID-19 vaccine from BioNTech/Pfizer download document …